Literature DB >> 12379674

Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization.

Jutta Nesper1, Stefan Schild, Crystal M Lauriano, Anita Kraiss, Karl E Klose, Joachim Reidl.   

Abstract

Since the first occurrence of O139 Vibrio cholerae as a cause of cholera epidemics, this serogroup has been investigated intensively, and it has been found that its pathogenicity is comparable to that of O1 El Tor strains. O139 isolates express a thin capsule, composed of a polymer of repeating units structurally identical to the lipopolysaccharide (LPS) O side chain. In this study, we investigated the role of LPS O side chain and capsular polysaccharide (CPS) in intestinal colonization by with genetically engineered mutants. We constructed CPS-negative, CPS/LPS O side chain-negative, and CPS-positive/LPS O side chain-negative mutants. Furthermore, we constructed two mutants with defects in LPS core oligosaccharide (OS) assembly. Loss of LPS O side chain or CPS resulted in a approximately 30-fold reduction in colonization of the infant mouse small intestine, indicating that the presence of both LPS O side chain and CPS is important during the colonization process. The strain lacking both CPS and LPS O side chain and a CPS-positive, LPS O side chain-negative core OS mutant were both essentially unable to colonize. To characterize the role of surface polysaccharides in survival in the host intestine, resistance to several antimicrobial substances was investigated in vitro. These investigations revealed that the presence of CPS protects the cell against attack of the complement system and that an intact core OS is necessary for survival in the presence of bile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379674      PMCID: PMC130371          DOI: 10.1128/IAI.70.11.5990-5996.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Authors:  D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization.

Authors:  D Provenzano; K E Klose
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  Environmental signals modulate ToxT-dependent virulence factor expression in Vibrio cholerae.

Authors:  D A Schuhmacher; K E Klose
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

4.  Phagocytosis of Vibrio cholerae O139 Bengal by human polymorphonuclear leukocytes.

Authors:  M J Albert; F Qadri; N A Bhuiyan; S M Ahmad; M Ansaruzzaman; A Weintraub
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

5.  Structure of the capsular polysaccharide of Vibrio cholerae O139 synonym Bengal containing D-galactose 4,6-cyclophosphate.

Authors:  Y A Knirel; L Paredes; P E Jansson; A Weintraub; G Widmalm; M J Albert
Journal:  Eur J Biochem       Date:  1995-09-01

6.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor.

Authors:  M Iwanaga; K Yamamoto; N Higa; Y Ichinose; N Nakasone; M Tanabe
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

Review 8.  Genetic organization of the regions associated with surface polysaccharide synthesis in Vibrio cholerae O1, O139 and Vibrio anguillarum O1 and O2: a review.

Authors:  U H Stroeher; K E Jedani; P A Manning
Journal:  Gene       Date:  1998-11-26       Impact factor: 3.688

9.  Morphological and physical characterization of the capsular layer of Vibrio cholerae O139.

Authors:  Y Meno; M K Waldor; J J Mekalanos; K Amako
Journal:  Arch Microbiol       Date:  1998-10       Impact factor: 2.552

10.  The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae.

Authors:  P Berche; C Poyart; E Abachin; H Lelievre; J Vandepitte; A Dodin; J M Fournier
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  23 in total

1.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

2.  Bile salts induce resistance to polymyxin in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Julianne V Kus; Ahferom Gebremedhin; Vica Dang; Seav-Ly Tran; Anca Serbanescu; Debora Barnett Foster
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

3.  Staphylococcus aureus MnhF mediates cholate efflux and facilitates survival under human colonic conditions.

Authors:  Thippeswamy H Sannasiddappa; Graham A Hood; Kevan J Hanson; Adele Costabile; Glenn R Gibson; Simon R Clarke
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

4.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

5.  Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants.

Authors:  M Shamim Hasan Zahid; S M Nashir Udden; A S G Faruque; Stephen B Calderwood; John J Mekalanos; Shah M Faruque
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

6.  The capability of catabolic utilization of N-acetylneuraminic acid, a sialic acid, is essential for Vibrio vulnificus pathogenesis.

Authors:  Hee Gon Jeong; Man Hwan Oh; Byoung Sik Kim; Min Young Lee; Ho Jae Han; Sang Ho Choi
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

7.  Vibrio vulnificus biotype 2 serovar E gne but not galE is essential for lipopolysaccharide biosynthesis and virulence.

Authors:  Esmeralda Valiente; Natalia Jiménez; Susana Merino; Juan M Tomás; Carmen Amaro
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

8.  O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice.

Authors:  Karin Ilg; Kathrin Endt; Benjamin Misselwitz; Bärbel Stecher; Markus Aebi; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

Review 9.  Staying Alive: Vibrio cholerae's Cycle of Environmental Survival, Transmission, and Dissemination.

Authors:  Jenna G Conner; Jennifer K Teschler; Christopher J Jones; Fitnat H Yildiz
Journal:  Microbiol Spectr       Date:  2016-04

10.  Vibrio cholerae O139 requires neither capsule nor LPS O side chain to grow inside Acanthamoeba castellanii.

Authors:  Hadi Abd; Amir Saeed; Andrej Weintraub; Gunnar Sandström
Journal:  J Med Microbiol       Date:  2009-01       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.